"Respiratory clinical development requires in-depth clinical knowledge with precise assessments along with the integration of multiple data sources," said Mark Maietta, Chief Commercial Officer of YPrime. "Our unified eCOA and IRT+ platform, paired with CompleWare's respiratory expertise will help sponsors accelerate promising investigational medicines." Dr. John M. Weiler, CompleWare's President, said "CompleWare and YPrime recognize that knowledge and discernment come from experience. Both companies feature the balance of expertise in clinical research and perpetual innovation to be successful."

Ground-Breaking TechnologyCompleWare's CompleClinical® is a comprehensive eClinical solution for trial data management. Designed for seamless implementation, practical use, and straightforward control, CompleClinical enables rapid setup with existing applications and hardware. From capturing and validating, to sorting and reporting, CompleClinical ensures global site data are accurate, secure and available on-demand through a single login.

About YPrimeYPrime offers more than a decade of focused work with eClinical systems to expedite and improve the quality of patient management, clinical supplies, drug accountability and clinical data. Cloud-based IRT+ and eCOA platforms enable greater speed, precision and integration in clinical trial management. Data services tools eliminate data silos and help sponsors bring together fragmented clinical research data into contextual information they can act on. YPrime's technology and service offerings enable sponsors to move faster and more efficiently to their next development milestone.

View original content:http://www.prnewswire.com/news-releases/compleware-and-yprime-announce-partnership-agreement-300581684.html

SOURCE CompleWare

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.

Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished.Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.Full Disclaimer